Old Web
English
Sign In
Acemap
>
Paper
>
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
2020
Edward Gane
Ys Lim
P. Tangkijvanich
J OBeirne
Th. Lim
A Bakardjiev
X. Ding
L. Connolly
S Huang
J. Kim
P. Pang
Rmf Yuen
Keywords:
chronic hepatitis
Virology
RNA interference
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]